Largest health care companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
UnitedHealth Group leads the 170 health care companies ranked by net assets, at SAR 375.4B, ahead of Pfizer (SAR 324.4B) and Johnson & Johnson (SAR 305.9B). Figures as of 19 Nov 2026, 08:56 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupSAR 375.4B
- Median
- SAR 9.6B
- Combined market value
- SAR 34.12T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Kymera TherapeuticsKYMR · Health Care | SAR 5.9B | SAR 38.8B | SAR 454.36 | 0.32% down | 87% up | ||
| 102 | LifeStance Health GroupLFST · Health Care | SAR 5.7B | SAR 19.6B | SAR 51.65 | 2.82% down | 129% up | ||
| 103 | InsuletPODD · Health Care | SAR 5.7B | SAR 36.4B | SAR 525.06 | 3.69% down | 58% down | ||
| 104 | CencoraCOR · Health Care | SAR 5.7B | SAR 249.3B | SAR 1,306.51 | 0.64% down | 3% down | ||
| 105 | PenumbraPEN · Health Care | SAR 5.4B | SAR 47.4B | SAR 1,202.57 | 0.47% up | 13% up | ||
| 106 | MSA SafetyMSA · Health Care | SAR 5.1B | SAR 25.6B | SAR 665.61 | 2.67% up | 11% up | ||
| 107 | Option Care HealthOPCH · Health Care | SAR 5B | SAR 17.8B | SAR 118.94 | 0.25% up | 14% up | ||
| 108 | Krystal BiotechKRYS · Health Care | SAR 4.6B | SAR 35.1B | SAR 1,182.84 | 5.62% up | 46% up | ||
| 109 | LivaNovaLIVN · Health Care | SAR 4.5B | SAR 19.5B | SAR 354.62 | 2.85% up | 71% up | ||
| 110 | RadNetRDNT · Health Care | SAR 4.1B | SAR 21.2B | SAR 269.40 | 4.14% down | 7% down | ||
| 111 | Lantheus HoldingsLNTH · Health Care | SAR 4.1B | SAR 25B | SAR 382.60 | 0.20% up | 93% up | ||
| 112 | Ligand PharmaceuticalsLGND · Health Care | SAR 3.8B | SAR 22.4B | SAR 1,120.46 | 1.67% up | 43% up | ||
| 113 | Legend BiotechLEGN · Health Care | SAR 3.8B | SAR 11.8B | SAR 60.95 | 0.87% up | 42% down | ||
| 114 | ChemedCHE · Health Care | SAR 3.7B | SAR 26.6B | SAR 2,050.75 | 0.01% down | 27% up | ||
| 115 | Oscar HealthOSCR · Health Care | SAR 3.7B | SAR 32.1B | SAR 103.42 | 7.61% down | 112% up | ||
| 116 | PACS GroupPACS · Health Care | SAR 3.6B | SAR 27.6B | SAR 173.67 | 4.63% down | 188% up | ||
| 117 | Praxis Precision MedicinesPRAX · Health Care | SAR 3.3B | SAR 32B | SAR 1,144.77 | 0.04% up | 61% up | ||
| 118 | ImmunovantIMVT · Health Care | SAR 3.2B | SAR 25.7B | SAR 124.42 | 0.12% down | 43% up | ||
| 119 | 10x GenomicsTXG · Health Care | SAR 3B | SAR 28.2B | SAR 214.07 | 1.37% up | 260% up | ||
| 120 | HaemoneticsHAE · Health Care | SAR 3B | SAR 21B | SAR 460.85 | 1.60% up | 61% up | ||
| 121 | Alnylam PharmaceuticalsALNY · Health Care | SAR 3B | SAR 75.1B | SAR 560.40 | 4.54% down | 66% down | ||
| 122 | Belite BioBLTE · Health Care | SAR 2.9B | SAR 23.8B | SAR 586.02 | 0.94% down | 31% up | ||
| 123 | CG OncologyCGON · Health Care | SAR 2.8B | SAR 26.8B | SAR 300.08 | 1.34% up | 85% up | ||
| 124 | InsmedINSM · Health Care | SAR 2.8B | SAR 98.6B | SAR 449.37 | 1.69% down | 40% down | ||
| 125 | Spyre TherapeuticsSYRE · Health Care | SAR 2.7B | SAR 36.1B | SAR 380.58 | 8.15% up | 286% up | ||
| 126 | Summit TherapeuticsSMMT · Health Care | SAR 2.5B | SAR 31.5B | SAR 39.39 | 1.59% down | 36% down | ||
| 127 | GlaukosGKOS · Health Care | SAR 2.5B | SAR 51.8B | SAR 874.28 | 4.18% down | 152% up | ||
| 128 | TG TherapeuticsTGTX · Health Care | SAR 2.4B | SAR 37.5B | SAR 248.02 | 5.44% up | 107% up | ||
| 129 | Corcept TherapeuticsCORT · Health Care | SAR 2.4B | SAR 27.8B | SAR 254.28 | 3.25% down | 8% down | ||
| 130 | Cogent BiosciencesCOGT · Health Care | SAR 2.4B | SAR 18.2B | SAR 104.32 | 0.14% down | 20% down | ||
| 131 | Protagonist TherapeuticsPTGX · Health Care | SAR 2.3B | SAR 31.1B | SAR 476.98 | 2.00% up | 46% up | ||
| 132 | Madrigal PharmaceuticalsMDGL · Health Care | SAR 2.3B | SAR 34.7B | SAR 1,493.20 | 5.67% down | 24% down | ||
| 133 | Caris Life SciencesCAI · Health Care | SAR 2.2B | SAR 21B | SAR 73.14 | 2.21% down | 17% down | ||
| 134 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SAR 2.1B | SAR 28B | SAR 356.53 | 0.06% down | 126% up | ||
| 135 | Hims & Hers HealthHIMS · Health Care | SAR 2B | SAR 15B | SAR 63.95 | 2.85% down | 51% down | ||
| 136 | Edgewise TherapeuticsEWTX · Health Care | SAR 2B | SAR 17B | SAR 155.18 | 1.59% down | 88% up | ||
| 137 | ABIVAXABVX · Health Care | SAR 1.9B | SAR 27.5B | SAR 314.45 | 2.11% up | 27% down | ||
| 138 | Dianthus TherapeuticsDNTH · Health Care | SAR 1.9B | SAR 17.7B | SAR 315.01 | 3.45% down | 113% up | ||
| 139 | Ionis PharmaceuticalsIONS · Health Care | SAR 1.8B | SAR 17.1B | SAR 102.74 | 1.59% up | 64% down | ||
| 140 | BillionToOneBLLN · Health Care | SAR 1.8B | SAR 16.4B | SAR 343.37 | 6.11% down | 0% up | ||
| 141 | Twist BioscienceTWST · Health Care | SAR 1.8B | SAR 29.8B | SAR 436.43 | 3.88% up | 340% up | ||
| 142 | Oruka TherapeuticsORKA · Health Care | SAR 1.8B | SAR 24.4B | SAR 359.12 | 0.60% down | 241% up | ||
| 143 | Arrowhead PharmaceuticalsARWR · Health Care | SAR 1.7B | SAR 22.9B | SAR 161.71 | 0.28% up | 10% up | ||
| 144 | Medpace HoldingsMEDP · Health Care | SAR 1.7B | SAR 67.9B | SAR 2,426.41 | 0.95% down | 10% up | ||
| 145 | Concentra Group Holdings ParentCON · Health Care | SAR 1.5B | SAR 19.8B | SAR 157.47 | 0.94% down | 120% up | ||
| 146 | Definium TherapeuticsDFTX · Health Care | SAR 1.2B | SAR 15B | SAR 109.23 | 0.88% down | 169% up | ||
| 147 | ErascaERAS · Health Care | SAR 1.2B | SAR 18.1B | SAR 51.61 | 0.94% down | 403% up | ||
| 148 | Mirum PharmaceuticalsMIRM · Health Care | SAR 1.2B | SAR 22.6B | SAR 346.93 | 0.59% up | 31% up | ||
| 149 | HeartflowHTFL · Health Care | SAR 1.1B | SAR 15.1B | SAR 172.13 | 2.51% down | 73% up | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | SAR 920.8M | SAR 22B | SAR 180.05 | 6.48% up | 14% up | ||
| 151 | Adaptive BiotechnologiesADPT · Health Care | SAR 820.7M | SAR 17.3B | SAR 106.75 | 0.11% down | 88% up | ||
| 152 | Kodiak SciencesKOD · Health Care | SAR 590.3M | SAR 24B | SAR 366.89 | 1.04% up | 396% up | ||
| 153 | Rhythm PharmaceuticalsRYTM · Health Care | SAR 521.6M | SAR 31B | SAR 446.52 | 2.08% up | 13% up | ||
| 154 | Travere TherapeuticsTVTX · Health Care | SAR 430.7M | SAR 18.1B | SAR 188.45 | 1.68% down | 44% up | ||
| 155 | Axsome TherapeuticsAXSM · Health Care | SAR 331.2M | SAR 26.4B | SAR 502.63 | 1.43% down | 7% down | ||
| 156 | Halozyme TherapeuticsHALO · Health Care | SAR 183.1M | SAR 41B | SAR 359.35 | 0.18% down | 37% up | ||
| 157 | Mettler-Toledo InternationalMTD · Health Care | -SAR 88.7M | SAR 129.6B | SAR 6,516.46 | 1.42% up | 22% up | ||
| 158 | Amneal PharmaceuticalsAMRX · Health Care | -SAR 265.5M | SAR 28.6B | SAR 82.07 | 3.60% up | 83% up | ||
| 159 | Guardant HealthGH · Health Care | -SAR 372.5M | SAR 73.7B | SAR 544.42 | 1.30% up | 44% up | ||
| 160 | VeradermicsMANE · Health Care | -SAR 453.9M | SAR 19.8B | SAR 468.35 | 0.62% down | 233% up | ||
| 161 | Ascendis PharmaASND · Health Care | -SAR 677.6M | SAR 66.5B | SAR 1,014.01 | 0.32% down | 28% up | ||
| 162 | PTC TherapeuticsPTCT · Health Care | -SAR 770.1M | SAR 18.9B | SAR 225.92 | 0.22% down | 20% down | ||
| 163 | ImmunityBioIBRX · Health Care | -SAR 1.9B | SAR 26.7B | SAR 25.13 | 7.03% up | 193% up | ||
| 164 | DaVitaDVA · Health Care | -SAR 2.4B | SAR 38.2B | SAR 606.87 | 6.48% down | 50% up | ||
| 165 | CytokineticsCYTK · Health Care | -SAR 2.5B | SAR 26.8B | SAR 192.50 | 0.64% down | 20% down | ||
| 166 | BridgeBio PharmaBBIO · Health Care | -SAR 7.8B | SAR 57B | SAR 292.62 | 1.58% up | 17% up | ||
| 167 | McKessonMCK · Health Care | -SAR 8.1B | SAR 469.6B | SAR 4,067.70 | 0.66% down | 28% up | ||
| 168 | Cardinal HealthCAH · Health Care | -SAR 10.8B | SAR 241.3B | SAR 1,043.98 | 0.33% down | 35% up | ||
| 169 | AbbVieABBV · Health Care | -SAR 12.3B | SAR 1.9T | SAR 1,072.82 | 2.33% down | 26% up | ||
| 170 | HCA HealthcareHCA · Health Care | -SAR 22.6B | SAR 373.2B | SAR 1,786.79 | 4.96% down | 4% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which health care companies rank first by net assets?
UnitedHealth Group (SAR 375.4B), Pfizer (SAR 324.4B) and Johnson & Johnson (SAR 305.9B) are the top three of the 170 health care companies ranked by net assets as of 19 Nov 2026, 08:56 UTC.
How many health care companies are in this ranking?
170 are ranked by net assets.
What are these health care companies worth together?
The 170 health care companies ranked by net assets have a combined market value of SAR 34.12T as of 19 Nov 2026, 08:56 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by net assets”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.